Polymer nanoparticles can be designed to improve the bioavailability of cancer drugs, which means the drugs are more easily absorbed and utilized by the body. They can also be engineered to target cancer cells specifically by attaching ligands that bind to receptors overexpressed on cancer cells. This targeted approach allows for higher concentrations of the drug to reach the tumor while sparing healthy tissues.
